Yuanyu Liao

150 Haping Road
Harbin, 150001, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Symptom clusters in oesophageal cancer patients during varying phases of postoperative chemotherapy: a scoping review.

Symptom clusters in oesophageal cancer patients during varying phases of postoperative chemotherapy: a scoping review.

Journal: BMJ open

Published: January 09, 2026

Targeting CTGF overcomes resistance to CSF1R inhibitors by preventing CAF activation in colorectal cancer.

Targeting CTGF overcomes resistance to CSF1R inhibitors by preventing CAF activation in colorectal cancer.

Journal: Cell reports. Medicine

Published: March 26, 2025

USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment.

USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment.

Journal: Cancer immunology research

Published: November 26, 2024

TRIM21 Promotes Tumor Growth and Gemcitabine Resistance in Pancreatic Cancer by Inhibiting EPHX1-Mediated Arachidonic Acid Metabolism.

TRIM21 Promotes Tumor Growth and Gemcitabine Resistance in Pancreatic Cancer by Inhibiting EPHX1-Mediated Arachidonic Acid Metabolism.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: October 25, 2024

Tumor aggression-defense index-a novel indicator to predicts recurrence and survival in stage II-III colorectal cancer.

Tumor aggression-defense index-a novel indicator to predicts recurrence and survival in stage II-III colorectal cancer.

Journal: Journal of translational medicine

Published: September 18, 2024

Mevalonate kinase inhibits anti-tumor immunity by impairing the tumor cell-intrinsic interferon response in microsatellite instability colorectal cancer.

Mevalonate kinase inhibits anti-tumor immunity by impairing the tumor cell-intrinsic interferon response in microsatellite instability colorectal cancer.

Journal: Oncogene

Published: July 29, 2024

Targeting Arachidonic Acid Metabolism Enhances Immunotherapy Efficacy in ARID1A-Deficient Colorectal Cancer.

Targeting Arachidonic Acid Metabolism Enhances Immunotherapy Efficacy in ARID1A-Deficient Colorectal Cancer.

Journal: Cancer research

Published: May 23, 2024

Efficacy and safety of immune checkpoint inhibitors in solid tumor patients combined with chronic coronary syndromes or its risk factor: a nationwide multicenter cohort study.

Efficacy and safety of immune checkpoint inhibitors in solid tumor patients combined with chronic coronary syndromes or its risk factor: a nationwide multicenter cohort study.

Journal: Cancer immunology, immunotherapy : CII

Published: May 05, 2024

Inhibition of HDAC2 sensitises antitumour therapy by promoting NLRP3/GSDMD-mediated pyroptosis in colorectal cancer.

Inhibition of HDAC2 sensitises antitumour therapy by promoting NLRP3/GSDMD-mediated pyroptosis in colorectal cancer.

Journal: Clinical and translational medicine

Published: December 26, 2023

A "One Arrow Three Eagle" Strategy to Improve CM-272 Primed Bladder Cancer Immunotherapy.

A "One Arrow Three Eagle" Strategy to Improve CM-272 Primed Bladder Cancer Immunotherapy.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: October 10, 2023

Employing Piezoelectric Mg2+-Doped Hydroxyapatite to Target Death Receptor-Mediated Necroptosis: A Strategy for Amplifying Immune Activation.

Employing Piezoelectric Mg2+-Doped Hydroxyapatite to Target Death Receptor-Mediated Necroptosis: A Strategy for Amplifying Immune Activation.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: September 27, 2023

EDARADD promotes colon cancer progression by suppressing E3 ligase Trim21-mediated ubiquitination and degradation of Snail.

EDARADD promotes colon cancer progression by suppressing E3 ligase Trim21-mediated ubiquitination and degradation of Snail.

Journal: Cancer letters

Published: June 26, 2023

Showing 1-12 of 18

Last Updated: 09/26/2026